ARHI (DIRAS3) induces autophagy in ovarian cancer cells by downregulating the epidermal growth factor receptor, inhibiting PI3K and Ras/MAP signaling and activating the FOXo3a-mediated induction of Rab7

Zhen Lü(The University of Texas MD Anderson Cancer Center), Robert C. Bast(The University of Texas MD Anderson Cancer Center)

Cell Death and Differentiation

April 25, 2014

10.1038/cdd.2014.48

Cited by 78

Related Papers

Genes Affecting the Cell Cycle, Growth, Maintenance, and Drug Sensitivity Are Preferentially Regulated by Anti-HER2 Antibody through Phosphatidylinositol 3-Kinase-AKT Signaling

|Journal of Biological Chemistry|2004|71

Modulation of MicroRNA-194 and Cell Migration by HER2-Targeting Trastuzumab in Breast Cancer

|PLoS ONE|2012|66

ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts

|Cell Death and Disease|2015|62

The role of vascular endothelial growth factor, interleukin 8, and insulinlike growth factor in sustaining autophagic DIRAS3‐induced dormant ovarian cancer xenografts

|Cancer|2019|32

Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer

|British Journal of Cancer|2024|27